Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

Cell

Volumn 118, Issue 4, 2004, Pages 493-504

  Malumbres, Marcos ^a   Sotillo, Rocío ^a   Santamaría, David ^a   Galán, Javier ^a   Cerezo, Ana ^a   Ortega, Sagrario ^a   Dubus, Pierre ^b   Barbacid, Mariano ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CDK4 PROTEIN, MOUSE; CDK6 PROTEIN, MOUSE; COMPLEMENTARY DNA; MITOGENIC AGENT; ONCOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE S PHASE; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; KINETICS; MAMMAL CELL; MITOGENESIS; MOUSE; NONHUMAN; NULL CELL; PRIORITY JOURNAL; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL CYCLE; CELL DIVISION; CULTURE TECHNIQUE; GENETIC PROCEDURES; GENETICS; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; TIME; TRANSGENE;

ANIMALIA; MAMMALIA;

ANIMALS; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASES; DNA, COMPLEMENTARY; FIBROBLASTS; GENETIC TECHNIQUES; HEMATOPOIETIC STEM CELLS; IMMUNOHISTOCHEMISTRY; KINETICS; LYMPHOCYTES; MICE; MICE, KNOCKOUT; MITOGENS; MODELS, GENETIC; PROTO-ONCOGENE PROTEINS; S PHASE; TIME FACTORS; TRANSGENES;

EID: 4444247138     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2004.08.002     Document Type: Article

References (42)

1. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 404:2000;193-197
2. Amanatullah D.F., Zafonte B.T., Albanese C., Fu M., Messiers C., Hassell J., Pestell R.G. Ras regulation of cyclin D1 promoter. Methods Enzymol. 333:2001;116-127
3. Berthet C., Aleem E., Coppola V., Tessarollo L., Kaldis P. Cdk2 knockout mice are viable. Curr. Biol. 13:2003;1775-1785
4. Ciemerych M.A., Kenney A.M., Sicinska E., Kalaszczynska I., Bronson R.T., Rowitch D.H., Gardner H., Sicinski P. Development of mice expressing a single D-type cyclin. Genes Dev. 16:2002;3277-3289
5. Classon M., Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer. 2:2002;910-917
6. Fantl V., Stamp G., Andrews A., Rosewell I., Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:1995;2364-2372
7. Geng Y., Yu Q., Sicinska E., Das M., Schneider J.E., Bhattacharya S., Rideout W.M., Bronson R.T., Gardner H., Sicinski P. Cyclin E ablation in the mouse. Cell. 114:2003;431-443
8. Hanahan D., Weinberg R. The hallmarks of cancer. Cell. 100:2000;57-70
9. Harbour J.W., Dean D.C. The Rb/E2F pathway. expanding roles and emerging paradigms Genes Dev. 14:2000;2393-2409
10. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell. 98:1999;859-869
11. Kozar K., Ciemerych M.A., Rebel V.I., Shigematsu H., Zagozdzon A., Sicinska E., Geng Y., Yu Q., Bhattacharya S., Bronson R.T., Akashi K., Sicinski P. Mouse development and cell proliferation in the absence of D-cyclins. Cell. 118:2004;477-491., this issue
12. Lukas J., Bartkova J., Welcker M., Petersen O.W., Peters G., Strauss M., Bartek J. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene. 10:1995;2125-2134
13. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:1998;753-761
14. Malumbres M., Barbacid M. To cycle or not to cycle. a critical decision in cancer Nat. Rev. Cancer. 1:2001;222-231
15. Martín J., Hunt S.L., Dubus P., Sotillo R., Néhmé- Pélluard F., Magnuson M.A., Parlow A.F., Malumbres M., Ortega S., Barbacid M. Genetic rescue of Cdk4 null mice restores pancreatic β-cell proliferation but not homeostatic cell number. Oncogene. 22:2003;5261-5269
16. Matsushime H., Ewen M.E., Strom D.K., Kato J.K., Hanks S.K., Roussel M.F., Sherr C.J. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell. 71:1992;323-334
17. Matushansky I., Radparvar F., Skoultchi A.I. Reprogramming leukemic cells to terminal differentiation by inhibiting specific cyclin-dependent kinases in G1. Proc. Natl. Acad. Sci. USA. 97:2000;14317-14322
18. Meyer C.A., Jacobs H.W., Datar S.A., Du W., Edgar B.A., Lehner C.F. Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression. EMBO J. 19:2000;4533-4542
19. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:1994;2077-2086
20. Meyerson M., Enders G., Wu C.L., Su L.K., Gorka C., Nelson C., Harlow E., Kato J.Y. A family of human cdc2-related protein kinases. EMBO J. 11:1992;2909-2917
21. Moons D.S., Jirawatnotai S., Parlow A.F., Gibori G., Kineman R.D., Kiyokawa H. Pituitary hypoplasia and lactotroph dysfunction in mice deficient for cyclin-dependent kinase-4. Endocrinology. 143:2002;3001-3008
22. Morris E.J., Dyson N.J. Retinoblastoma protein partners. Adv. Cancer Res. 82:2001;1-54
23. Ortega S., Prieto I., Odajima J., Martín A., Dubus P., Sotillo R., Barbero J.L., Malumbres M., Barbacid M. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat. Genet. 35:2003;25-31
24. Parisi T., Beck A.R., Rougier N., McNeil T., Lucian L., Werb Z., Amati B. Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J. 22:2003;4794-4803
25. Park M., Krause M.W. Regulation of postembryonic G(1) cell cycle progression in Caenorhabditis elegans by a cyclin D/CDK-like complex. Development. 126:1999;4849-4860
26. Pavletich N.P. Mechanisms of cyclin-dependent kinase regulation. structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors J. Mol. Biol. 287:1999;821-828
27. Rane S.G., Dubus P., Mettus R.V., Galbreath E.J., Boden G., Reddy E.P., Barbacid M. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-cell hyperplasia. Nat. Genet. 22:1999;44-52
28. Ren S., Rollins B.J. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell. 117:2004;239-251
29. Sherr C.J., Roberts J.M. Cdk inhibitors. positive and negative regulators of G1-phase progression Genes Dev. 13:1999;1501-1512
30. Sicinska E., Aifantis I., Le Cam L., Swat W., Borowski C., Yu Q., Ferrando A.A., Levin S.D., Geng Y., von Boehmer H., Sicinski P. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell. 4:2003;451-461
31. Sicinski P., Donaher J.L., Parker S.B., Li T., Fazeli A., Gardner H., Haslam S.Z., Bronson R.T., Elledge S.J., Weinberg R.A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 82:1995;621-630
32. Sicinski P., Donaher J.L., Geng Y., Parker S.B., Gardner H., Park M.Y., Robker R.L., Richards J.S., McGinnis L.K., Biggers J.D., et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature. 384:1996;470-474
33. Sotillo R., Dubus P., Martín J., de la Cueva E., Ortega S., Malumbres M., Barbacid M. Wide spectrum of tumors in knock in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J. 20:2001;6637-6647
34. Stacey D., Kazlauskas A. Regulation of Ras signaling by the cell cycle. Curr. Opin. Genet. Dev. 12:2002;44-46
35. Steinman R.A. Cell cycle regulators and hematopoiesis. Oncogene. 21:2002;3403-3413
36. Stevaux O., Dyson N.J. A revised picture of the E2F transcriptional network and RB function. Curr. Opin. Cell Biol. 14:2002;684-691
37. Sweeney K.J., Sarcevic B., Sutherland R.L., Musgrove E.A. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells. Oncogene. 14:1997;1329-1340
38. Traver D., Miyamoto T., Christensen J., Iwasaki-Arai J., Akashi K., Weissman I.L. Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets. Blood. 98:2001;627-635
39. Tsutsui T., Hesabi B., Moons D.S., Pandolfi P.P., Hansel K.S., Koff A., Kiyokawa H. Targeted disruption of Cdk4 delays cell cycle entry with enhanced p27Kip1 activity. Mol. Cell. Biol. 19:1999;7011-7019
40. Tybulewicz V.L., Crawford C.E., Jackson P.K., Bronson R.T., Mulligan R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 65:1991;1153-1163
41. Xiong Y., Zhang H., Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 71:1992;505-514
42. Ye X., Zhu C., Harper J.W. A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene. Proc. Natl. Acad. Sci. USA. 98:2001;1682-1686